 TORRANCE, Calif., Sept. 2, 2021 PRNewswire -- Emmaus Life Sciences, Inc. OTC: EMMA, a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced financial results for the six months ended June 30, 2021. 